Literature DB >> 11689477

A role for mitogen-activated protein kinases in the etiology of diabetic neuropathy.

T Purves1, A Middlemas, S Agthong, E B Jude, A J Boulton, P Fernyhough, D R Tomlinson.   

Abstract

The onset of diabetic neuropathy, a complication of diabetes mellitus, has been linked to poor glycemic control. We tested the hypothesis that the mitogen-activated protein kinases (MAPK) form transducers for the damaging effects of high glucose. In cultures of adult rat sensory neurons, high glucose activated JNK and p38 MAPK but did not result in cell damage. However, oxidative stress activated ERK and p38 MAPKs and resulted in cellular damage. In the dorsal root ganglia of streptozotocin-induced diabetic rats (a model of type I diabetes), ERK and p38 were activated at 8 wk duration, followed by activation of JNK at 12 wk duration. We report activation of JNK and increases in total levels of p38 and JNK in sural nerve of type I and II diabetic patients. These data implicate MAPKs in the etiology of diabetic neuropathy both via direct effects of glucose and via glucose-induced oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11689477     DOI: 10.1096/fj.01-0253hyp

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  80 in total

1.  GLP-1 signals via ERK in peripheral nerve and prevents nerve dysfunction in diabetic mice.

Authors:  C G Jolivalt; M Fineman; C F Deacon; R D Carr; N A Calcutt
Journal:  Diabetes Obes Metab       Date:  2011-11       Impact factor: 6.577

2.  Baicalein alleviates diabetic peripheral neuropathy through inhibition of oxidative-nitrosative stress and p38 MAPK activation.

Authors:  Roman Stavniichuk; Viktor R Drel; Hanna Shevalye; Yury Maksimchyk; Tamara M Kuchmerovska; Jerry L Nadler; Irina G Obrosova
Journal:  Exp Neurol       Date:  2011-04-16       Impact factor: 5.330

3.  Taurine reduces nitrosative stress and nitric oxide synthase expression in high glucose-exposed human Schwann cells.

Authors:  Trevor Askwith; Wei Zeng; Margaret C Eggo; Martin J Stevens
Journal:  Exp Neurol       Date:  2011-09-17       Impact factor: 5.330

4.  Mitochondrial stress and the pathogenesis of diabetic neuropathy.

Authors:  Paul Fernyhough; Subir K Roy Chowdhury; Robert E Schmidt
Journal:  Expert Rev Endocrinol Metab       Date:  2010-01-01

5.  Peroxynitrite and protein nitration in the pathogenesis of diabetic peripheral neuropathy.

Authors:  Roman Stavniichuk; Hanna Shevalye; Sergey Lupachyk; Alexander Obrosov; John T Groves; Irina G Obrosova; Mark A Yorek
Journal:  Diabetes Metab Res Rev       Date:  2014-11       Impact factor: 4.876

6.  Interplay of sorbitol pathway of glucose metabolism, 12/15-lipoxygenase, and mitogen-activated protein kinases in the pathogenesis of diabetic peripheral neuropathy.

Authors:  Roman Stavniichuk; Hanna Shevalye; Hiroko Hirooka; Jerry L Nadler; Irina G Obrosova
Journal:  Biochem Pharmacol       Date:  2012-01-20       Impact factor: 5.858

7.  Aldose reductase inhibition counteracts oxidative-nitrosative stress and poly(ADP-ribose) polymerase activation in tissue sites for diabetes complications.

Authors:  Irina G Obrosova; Pal Pacher; Csaba Szabó; Zsuzsanna Zsengeller; Hiroko Hirooka; Martin J Stevens; Mark A Yorek
Journal:  Diabetes       Date:  2005-01       Impact factor: 9.461

8.  12/15-Lipoxygenase inhibition counteracts MAPK phosphorylation in mouse and cell culture models of diabetic peripheral neuropathy.

Authors:  Roman Stavniichuk; Alexander A Obrosov; Viktor R Drel; Jerry L Nadler; Irina G Obrosova; Mark A Yorek
Journal:  J Diabetes Mellitus       Date:  2013-08

9.  Epoxy fatty acids mediate analgesia in murine diabetic neuropathy.

Authors:  K Wagner; K S S Lee; J Yang; B D Hammock
Journal:  Eur J Pain       Date:  2016-09-15       Impact factor: 3.931

10.  Prevention of diabetes-induced arginase activation and vascular dysfunction by Rho kinase (ROCK) knockout.

Authors:  Lin Yao; Surabhi Chandra; Haroldo A Toque; Anil Bhatta; Modesto Rojas; Ruth B Caldwell; R William Caldwell
Journal:  Cardiovasc Res       Date:  2012-12-17       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.